Tirzepatide represents a groundbreaking treatment agent for individuals battling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://tamzinktbx558090.timeblog.net/76419637/tirzepatide-a-new-frontier-in-diabetes-treatment